{
  "id": 15538446,
  "title": "Your lung health should not have to wait",
  "url": "https://urgent.news/2026/10/19/your-lung-health-should-not-have-to-wait",
  "topic": "world",
  "section": "World",
  "published": "2026-10-19T02:00:00.000Z",
  "source": {
    "name": "The National UAE",
    "slug": "the-national-uae",
    "url": "https://www.thenationalnews.com/advertorial/2026/10/19/your-lung-health-should-not-have-to-wait/"
  },
  "original_language": "en",
  "account": "Every year, an estimated 9.2 million individuals worldwide may be grappling with idiopathic or progressive pulmonary fibrosis. Yet, there exist no figures that shed light on how many individuals delay seeking medical help for persistent coughs. This discrepancy between numbers and actions holds significant weight. Pulmonary fibrosis is not a condition that can be cured; it worsens over time, thickening and stiffening the lungs, which should be elastic and flexible. As the disease progresses, even everyday tasks become strenuous, leading to an overall decline in quality of life. The impact extends beyond the physical realm, affecting emotional and social aspects as well. Patients lose their independence, and families are burdened with additional responsibilities. Despite this, studies have shown that diagnosis could potentially be delayed by a year or two, as early symptoms are often mistaken for signs of aging, decreased fitness, or more common respiratory ailments. During this period, patients often attribute their symptoms to natural aging processes, expecting their condition to improve on its own, and therefore, shy away from consulting a doctor, possibly due to fear of hearing the diagnosis or simply not recognizing the symptoms for what they truly are. The Elevator Campaign aims to address this hesitation. It reminds us of those crucial moments when we know we need to discuss our health concerns but keep postponing. It urges us not to postpone these appointments. The delay has a tangible cost that one cannot afford to bear. In recent years, the field of pulmonary fibrosis has witnessed considerable progress. We have moved away from accepting minimal treatment options to understanding the importance of early intervention. However, we have also realized that merely having a treatment option is not sufficient. The real challenges lie in ensuring treatment adherence, managing side effects, and maintaining patient quality of life. Thus, the conversation must evolve. The question is not just whether a treatment can slow down the progression of the disease, but whether it enables patients to stay on the treatment path, which is vital for managing their condition effectively. The approval of a new treatment option in the UAE underscores the advancements in this field. It presents an opportunity to rethink how we approach pulmonary fibrosis. Rather than viewing it as a disease that patients must endure with limited choices and tough decisions, we should consider it as a condition where early detection and consistent, tolerable treatment can significantly affect the patient's journey. This approach is not about replacing one drug with another; it's about empowering patients with accessible, sustainable, and truly patient-centered treatment. When patients can adhere to therapy without compromising their daily lives, we have started making a real difference. However, one new therapy alone will not suffice. The gaps remain vast. Up to half of those diagnosed still do not receive any treatment at all. The disease remains underdiagnosed and often misunderstood. This is why we will continue to invest in research, collaborations, and education. Your lungs deserve the same level of attention you give to other parts of your health. A persistent cough is not a normal occurrence. Difficulty in breathing even with minimal effort is not a sign of aging. Increasing fatigue that worsens over time is not something to endure. It's crucial to consult with your healthcare professional. Get checked. Seek answers. Start treatment early, as early intervention can change outcomes for those living with pulmonary fibrosis. That is what we are advocating for - a healthier future for your lungs, the ability to breathe without struggle, and the realization of the future you truly deserve.",
  "summary": "Estimates suggest that as many as 9.2 million people worldwide may be living with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis. But there are no statistics that tell how many people put off going to the doctor to get that nagging cough checked. That gap between numbers and behaviour is everything. Pulmonary fibrosis is progressive and irreversible. It scars the lungs, making…",
  "key_points": [
    "9.2 million people worldwide may have idiopathic or progressive pulmonary fibrosis.",
    "Delay in seeking medical help for persistent coughs could be a year or two.",
    "Early intervention can significantly change outcomes for pulmonary fibrosis patients."
  ],
  "editors_take": "Prioritizing early detection and patient-centered treatment protocols shifts the focus from merely slowing disease progression to ensuring long-term adherence and maintaining the quality of life for those living with pulmonary fibrosis.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The National Business",
        "title": "Your lung health should not have to wait",
        "url": "https://urgent.news/2026/10/19/your-lung-health-should-not-have-to-wait-15541008",
        "published": "2026-10-19T02:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}